UCB - Pre Tax Profit

Stock Price
225.20
Daily Change
-2.50 -1.10%
Monthly
-11.13%
Yearly
39.75%
Q2 Forecast
233.96

UCB reported EUR789M in Pre-Tax Profit for its fiscal semester ending in June of 2025.





Pre Tax Profit Change Date
Alcon AG USD 264M 19M Dec/2025
Almirall EUR 30.32M 22M Dec/2025
Amarin USD -852K 7.26M Dec/2025
argenx SE USD 386.05M 99.15M Sep/2025
AstraZeneca USD 3.24B 117M Sep/2025
Bayer EUR -1.16B 735M Sep/2025
Galapagos EUR -221.49M 117.07M Sep/2025
Genmab DKK 55M 427M Dec/2025
GlaxoSmithKline GBP 1.23B 1.23B Dec/2025
GRIFOLS EUR 190.51M 20.03M Jun/2025
Hikma Pharmaceutical USD 147.5M 3.5M Jun/2025
Lonza CHF 624M 197M Dec/2024
Merck EUR 1.29B 458.1M Sep/2025
Novartis USD 4.64B 445M Dec/2025
Orion EUR 113.4M 213.6M Mar/2026
Recordati EUR 144.95M 25.46M Sep/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sanofi EUR -1.16B 5.5B Dec/2025
UCB EUR 789M 427M Jun/2025